Constraint-Induced Movement Therapy for Adults Post-Stroke With Mild Upper Extremity Impairment and Deficits in Desired Occupational Performance: A Pilot Study
概览
- 阶段
- 不适用
- 干预措施
- Grade 1 CI Therapy +Sensory Components
- 疾病 / 适应症
- CVA (Cerebrovascular Accident)
- 发起方
- University of Alabama at Birmingham
- 入组人数
- 12
- 试验地点
- 1
- 主要终点
- 45-Item Motor Activity Log (MAL)
- 状态
- 招募中
- 最后更新
- 2个月前
概览
简要总结
Constraint-Induced Therapy (CI Therapy) is a behavioral approach to neurorehabilitation and consists of multi-components that have been applied in a systematic method to improve the use of the limb or function addressed in the intensive treatment. CI Therapy for the more-affected upper extremity (UE) post-stroke is administered in daily treatment sessions over consecutive weekdays. Sessions include motor training with repeated, timed trials using a technique called shaping, a set of behavioral strategies known as the Transfer Package (TP) to improve the use of the more-affected hand in the life situation, and strategies to remind participants to use the more-affected UE including restraint. Robust improvements in the amount and qualify of use have been realized with stroke participants from mild-to-severe UE impairment.
详细描述
Previous CI therapy studies have explored treatment for participants with varied levels of motor impairment from mild-to-severe that have limited use of the more-affected arm and hand in everyday activities as measured by the Motor Activity Log (MAL). The Motor Activity Log (MAL) is a standardized test used in CI therapy studies to measure the Amount of Use and the Quality of Use of the more-affected UE in the life situation. Individuals that exceed maximal criteria with a mean MAL score higher than 2.5 are typically excluded from CI therapy studies since they potentially would hit a ceiling effect on the MAL and would not be able to show a meaningful treatment change. Similarly, in a clinical setting, these individuals are often discharged from outpatient therapy as having reached the maximum benefit of traditional therapy since each can typically perform basic skills with the more-affected UE despite the disparity of continued difficulty with performing high-level motor tasks and persistent sensory deficits. However, these patients often voice strong motivation to gain more recovery and return to performing activities of daily living (ADL) and instrumental activities of daily living (IADL)that require complex motor skills (i.e.; keyboarding, texting, utensil or tool use, musical instrument use, etc). We hypothesize that participants with mild UE movement deficits will benefit from CI therapy with focused intervention to address skills and performance of high-level tasks and outcome measures that are selected for this level of patient. We further question if adding sensory components to the CI therapy strategies will improve the participant's sensation for the more-affected UE and aid in the more-affected UE use in everyday tasks but particularly in challenging motor tasks.
研究者
Mary H Bowman
Assistant Professor
University of Alabama at Birmingham
入排标准
入选标准
- •At least 6 months post stroke
- •The ability to demonstrate the minimum UE active movement criteria of 20 degrees of wrist extension from a fully flexed position, 10 degrees of thumb extension or abduction, and 10 degrees of extension of all finger joints.
- •Mean score of \>2.5 on the Motor Activity Log indicating the participant's use of the more-affected UE.
排除标准
- •Score\< 24 on the Mini Mental State Exam
- •Inability to answer the MAL questions and/or provide informed consent
- •The inability to come in to the laboratory setting for treatment.
研究组 & 干预措施
Grade 1 CI Therapy + Sensory Components
All participants will receive the Grade 1 CI Therapy + Sensory Components administered over a two-week period of time.
干预措施: Grade 1 CI Therapy +Sensory Components
结局指标
主要结局
45-Item Motor Activity Log (MAL)
时间窗: At 3 months after the end of the treatment
The 45-Item MAL is a semi-structured interview that assesses the amount of use and the quality of use of the more-affected UE in 45 activities of daily living. The use of this test is to determine the change how much and how well the participant uses the more-affected arm and hand outside of the laboratory setting. It is administered before and after treatment. The score is derived from a 0-5 scale and reported as a mean for the Amount of Use (AOU) and the Quality of Use (QOM).
Wolf Motor Function Test (WMFT)
时间窗: At post treatment after the 2 weeks of intervention
The WMFT is a standardized test that measures the motor ability of the upper extremities of a participant. The performance time by stopwatch is recorded and functional ability (quality) score is provided for each item tested. It is administered before treatment and after treatment. The quality of movement is rated by the therapist on a scale from 0-5 with 0 representing the participant's inability to perform the task, and 5 representing normal movement or as good as before the stroke, such that a higher functional ability score is better. A lower performance represents a better performance.
Canadian Occupational Performance Measure (COPM)
时间窗: At follow-up at 3 months following the end of treatment.
The COPM is a semi structured interview in which the participant is asked to rate desired occupational performance areas for activities of daily living and instrumental activities of daily living. The COPM is used to show changes in performance and satisfaction in desired areas of occupational performance. There are three scales used in the COPM administration one for importance, performance, and satisfaction. The scales range from 1-10 with the higher score indicating an improvement in the score.
45-Item Motor Activity Log (MAL)
时间窗: At post treatment after 2 weeks of intervention
The 45-Item MAL is a semi-structured interview that assesses the amount of use and the quality of use of the more-affected UE in 45 activities of daily living. The use of this test is to determine the change how much and how well the participant uses the more-affected arm and hand outside of the laboratory setting. It is administered before and after treatment. The score is derived from a 0-5 scale and reported as a mean for the Amount of Use (AOU) and the Quality of Use (QOM).
Canadian Occupational Performance Measure (COPM)
时间窗: At post-treatment after the 2 weeks of intervention
The COPM is a semi structured interview in which the participant is asked to rate desired occupational performance areas for activities of daily living and instrumental activities of daily living. The COPM is used to show changes in performance and satisfaction in desired areas of occupational performance. There are three scales used in the COPM administration one for importance, performance, and satisfaction. The scales range from 1-10 with the higher score indicating an improvement in the score.
次要结局
- Beck Depression Inventory (BDI)(At 3 month follow up from the end of the 2 weeks of treatment.)
- Stroke Impact Scale (SIS)(At 3 months following the end of the 2 weeks of treatment.)
- Semmes-Weinstein Monofilament Test (SWMT)(At post-treatment after the 2 weeks of intervention)
- 9 Hole Peg Test (9HPT)(At post-treatment after the 2 weeks of intervention)
- Revised Nottingham Sensory Assessment (rNSA)(At post-treatment after the 2 weeks of intervention)
- Beck Depression Inventory (BDI)(At post- treatment following the 2 weeks of treatment)
- Stroke Impact Scale (SIS)(At post-treatment following the 2 weeks of treatment)